Use of peptide-drug conjugation to reduce inter-subject...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/00 (2006.01) A61K 47/48 (2006.01) A61K 49/00 (2006.01) C12Q 1/37 (2006.01)

Patent

CA 2477038

The present invention provides compositions and methods to decrease inter- patient variability particularly with respect to the systemic concentration of a drug. More particularly the invention relates to oral drugs which are conjugated to peptides or related carriers which alter release characteristics as compared to the analogous free drug. Figure (1) illustrates a typical release profile for reference drug v. a peptide conjugate drug of the present invention.

L'invention concerne des compositions et des procédés permettant de diminuer la variabilité entre des patients, plus spécifiquement par rapport à la concentration systémique d'un médicament. Plus spécifiquement, l'invention concerne des médicaments administrés par voie orale conjugués à des peptides ou des excipients associés qui modifient les caractéristiques de libération en comparaison du médicament libre analogue.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of peptide-drug conjugation to reduce inter-subject... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of peptide-drug conjugation to reduce inter-subject..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of peptide-drug conjugation to reduce inter-subject... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1634701

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.